LENZ Therapeutics Inc (LENZ) stock news · rev $19.1M
LENZ Therapeutics Inc (LENZ) is a biotechnology company listed on US.
This LENZ news page leads with what LENZ Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for LENZ yet. We will not pad this page with generic market recap.
Latest reported LENZ revenue for 2025-12-31 was $19.1M. Net income was -$82.1M. LENZ currently screens at market cap $223.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the LENZ stock page; for the tape open the quote page.
LENZ stock news FAQ
What are LENZ's latest revenue and net income?
Latest cached LENZ Therapeutics Inc (LENZ) revenue for Dec 31, 2025 was $19.1M. Net income was -$82.1M. Statements: https://lician.com/financials/lenz
What is LENZ's market cap?
LENZ Therapeutics Inc (LENZ) market cap is $223.6M on the latest cached fundamentals snapshot.
What kind of company is LENZ?
LENZ Therapeutics Inc (LENZ) is a biotechnology company listed on US.
Where is LENZ stock news listed?
Cached stock news for LENZ Therapeutics Inc (LENZ) is listed at https://lician.com/news/lenz. Filings: https://lician.com/sec/lenz
Not investment advice.